Page last updated: 2024-11-05

urapidil and Arterial Occlusive Diseases

urapidil has been researched along with Arterial Occlusive Diseases in 1 studies

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"Urapidil is an alpha-adrenergic receptor antagonist with serotonin-1A receptor-agonist activity in the central nervous system."2.67Blood pressure management during aortic surgery: urapidil compared to isosorbide dinitrate. ( Lacroix, H; Nevelsteen, A; Suy, R; Van Aken, H; Van Hemelrijck, J; Waets, P, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Hemelrijck, J1
Waets, P1
Van Aken, H1
Lacroix, H1
Nevelsteen, A1
Suy, R1

Trials

1 trial available for urapidil and Arterial Occlusive Diseases

ArticleYear
Blood pressure management during aortic surgery: urapidil compared to isosorbide dinitrate.
    Journal of cardiothoracic and vascular anesthesia, 1993, Volume: 7, Issue:3

    Topics: Alfentanil; Anesthesia, Intravenous; Aortic Aneurysm, Abdominal; Aortic Diseases; Arterial Occlusive

1993